These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 34425093)

  • 1. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
    Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
    Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
    Parlak E; Kosar Y; Ulker A; Dagli U; Alkim C; Sahin B
    J Clin Gastroenterol; 2001 Oct; 33(4):299-301. PubMed ID: 11588543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of inflammatory bowel disease in patients with primary sclerosing cholangitis: A systematic review and meta-analysis.
    Zhang Y; Gao X; He Z; Jia H; Chen M; Wang X; Hong L; Cui Y; Wan J
    Liver Int; 2022 Aug; 42(8):1814-1822. PubMed ID: 35689520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran.
    Hadizadeh M; Abedi SH; Malekpour H; Radinnia E; Jabbehdari S; Padashi M; Zali MR; Mohammad Alizadeh AH
    Arab J Gastroenterol; 2016 Mar; 17(1):17-9. PubMed ID: 27032493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
    Pazenco EV; Karev VE; Raikhelson KL; Shchukina OB; Botina AV; Kharitonov AG; Semenov NV
    Eksp Klin Gastroenterol; 2016; (7):18-24. PubMed ID: 30284417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
    Rossi RE; Conte D; Massironi S
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Rocha HC; Vilela EG
    Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polygenic risk score predicts risk of primary sclerosing cholangitis in inflammatory bowel disease.
    Wang MH; Friton JJ; Raffals LE; Leighton JA; Pasha SF; Picco MF; Monroe K; Nix BD; Newberry RD; Faubion WA
    BMJ Open Gastroenterol; 2023 Oct; 10(1):. PubMed ID: 37832963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort.
    Isene R; Bernklev T; Høie O; Munkholm P; Tsianos E; Stockbrügger R; Odes S; Palm Ø; Småstuen M; Moum B;
    Scand J Gastroenterol; 2015 Mar; 50(3):300-5. PubMed ID: 25535653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease.
    Rasmussen HH; Fallingborg JF; Mortensen PB; Vyberg M; Tage-Jensen U; Rasmussen SN
    Scand J Gastroenterol; 1997 Jun; 32(6):604-10. PubMed ID: 9200295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysis.
    Mehta TI; Weissman S; Fung BM; Sotiriadis J; Lindor KD; Tabibian JH
    Liver Int; 2021 Oct; 41(10):2418-2426. PubMed ID: 34224208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease.
    Ananthakrishnan AN; Cagan A; Gainer VS; Cheng SC; Cai T; Szolovits P; Shaw SY; Churchill S; Karlson EW; Murphy SN; Kohane I; Liao KP
    J Crohns Colitis; 2014 Sep; 8(9):956-63. PubMed ID: 24559536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease in India.
    Singh A; Midha V; Narang V; Kedia S; Mahajan R; Dhoble P; Kahlon BK; Dhaliwal AS; Tripathi A; Kalra S; Jain NP; Bansal N; Banerjee R; Desai D; Dutta U; Ahuja V; Sood A
    Intest Res; 2023 Oct; 21(4):452-459. PubMed ID: 36453008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.